Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Главный автор: | Tamanna, Mst. Taskia |
---|---|
Другие авторы: | Sharmin, Dr. Sabrina |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
Brac University
2023
|
Предметы: | |
Online-ссылка: | http://hdl.handle.net/10361/18146 |
Схожие документы
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
по: Hassan, Md. Muhtaz
Опубликовано: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
по: Islam, Md. Irfath
Опубликовано: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
по: Alim, Abdul
Опубликовано: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
по: Parveen, Sanjana
Опубликовано: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
по: Tabassum, Nadira
Опубликовано: (2024)